Massachusetts Financial Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,709,248
Closed -$389M 855
2022
Q3
$389M Sell
4,709,248
-671,801
-12% -$55.5M 0.15% 160
2022
Q2
$512M Buy
5,381,049
+860,313
+19% +$81.8M 0.18% 139
2022
Q1
$532M Sell
4,520,736
-44,165
-1% -$5.2M 0.16% 148
2021
Q4
$591M Buy
4,564,901
+32,891
+0.7% +$4.26M 0.16% 147
2021
Q3
$513M Buy
4,532,010
+811,623
+22% +$91.9M 0.15% 155
2021
Q2
$385M Buy
3,720,387
+236,889
+7% +$24.5M 0.11% 176
2021
Q1
$291M Sell
3,483,498
-8,187
-0.2% -$685K 0.09% 198
2020
Q4
$319M Buy
3,491,685
+107,800
+3% +$9.83M 0.1% 185
2020
Q3
$270M Buy
3,383,885
+128,842
+4% +$10.3M 0.1% 194
2020
Q2
$225M Buy
3,255,043
+170,425
+6% +$11.8M 0.09% 197
2020
Q1
$194M Sell
3,084,618
-1,740,729
-36% -$109M 0.09% 187
2019
Q4
$375M Buy
4,825,347
+324,759
+7% +$25.3M 0.14% 154
2019
Q3
$330M Buy
4,500,588
+94,545
+2% +$6.93M 0.13% 156
2019
Q2
$271M Buy
4,406,043
+165,588
+4% +$10.2M 0.11% 170
2019
Q1
$270M Buy
4,240,455
+9,837
+0.2% +$627K 0.11% 163
2018
Q4
$216M Sell
4,230,618
-2,150,376
-34% -$110M 0.1% 181
2018
Q3
$370M Sell
6,380,994
-61,536
-1% -$3.57M 0.15% 146
2018
Q2
$313M Buy
6,442,530
+323,028
+5% +$15.7M 0.13% 160
2018
Q1
$285M Buy
6,119,502
+16,398
+0.3% +$763K 0.12% 166
2017
Q4
$229M Buy
6,103,104
+121,095
+2% +$4.55M 0.1% 183
2017
Q3
$218M Buy
5,982,009
+82,572
+1% +$3.01M 0.09% 185
2017
Q2
$233M Buy
5,899,437
+761,745
+15% +$30M 0.1% 177
2017
Q1
$161M Buy
5,137,692
+437,736
+9% +$13.7M 0.08% 201
2016
Q4
$147M Buy
4,699,956
+2,066,571
+78% +$64.5M 0.07% 212
2016
Q3
$106M Buy
2,633,385
+1,960,209
+291% +$78.8M 0.05% 250
2016
Q2
$22.4M Buy
+673,176
New +$22.4M 0.01% 479
2016
Q1
Sell
-38,958
Closed -$1.03M 846
2015
Q4
$1.03M Sell
38,958
-834,858
-96% -$22M ﹤0.01% 736
2015
Q3
$20.7M Sell
873,816
-102,756
-11% -$2.43M 0.01% 482
2015
Q2
$23.2M Buy
976,572
+23,250
+2% +$552K 0.01% 489
2015
Q1
$22.6M Buy
953,322
+922,488
+2,992% +$21.9M 0.01% 500
2014
Q4
$655K Buy
30,834
+3,042
+11% +$64.6K ﹤0.01% 828
2014
Q3
$473K Buy
+27,792
New +$473K ﹤0.01% 842